Oliceridine
Back to searchMolecule Structure
Scientific Name
Oliceridine
Description of the Drug
Oliceridine is a biased opioid agonist indicated for the management of severe acute pain in adult patients. Through preferential activation of G-protein-coupled signalling pathways, oliceridine provides analgesic effect with a comparable or improved safety profile over conventional opioid agonists.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB14881
http://www.drugbank.ca/drugs/DB14881
Brand Name(s)
Olinvyk, Olynvik
Company Owner(s)
Trevena Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Mu opioid receptor | SINGLE PROTEIN | AGONIST | CHEMBL233 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL12542370 |
| DrugBank | DB14881 |
| PubChem: Thomson Pharma | 152159759 |
| PubChem | 66553195 |
| PDBe | WH2 |
| BindingDB | 50493818 |
| DrugCentral | 5406 |
| ChemicalBook | CB12716393 |
| Guide to Pharmacology | 7334 |
| rxnorm | OLICERIDINE |
| ZINC | ZINC000096940334 |
